Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00930072 · ClinicalTrials.gov registry record · Phase 2
Safety Study of Cervical Sympathetic Block for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
A Phase 2 study, sponsored by University of Washington.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT00930072: Clinical Trial Phase 2 study, sponsored by University of Washington.
NCT00930072 is a Phase 2 study that was terminated before completion, run by University of Washington. The registered enrollment target is 7 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00930072, a Phase 2 study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
To evaluate the feasibility of performing a cervical sympathetic block in patients with severe cerebral vasospasm involving the anterior cerebral circulation following aneurysmal SAH.
Interventions
- DRUG Cervical Sympathetic Block (bupivicaine, clonidine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-04 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Why NCT00930072 stopped before completion
NCT00930072 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Cervical Sympathetic Block (bupivicaine, clonidine) is the first listed.
NCT00930072 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00930072 about?
NCT00930072 is a clinical study titled "Safety Study of Cervical Sympathetic Block for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage". To evaluate the feasibility of performing a cervical sympathetic block in patients with severe cerebral vasospasm involving the anterior cerebral circulation following aneurysmal SAH.
What is the current status of trial NCT00930072?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2009-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00930072?
The interventions under investigation include: Cervical Sympathetic Block (bupivicaine, clonidine) (DRUG).
Who is sponsoring clinical trial NCT00930072?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00930072's enrollment target sits among peer trials
7 1996th of 2000 higher than 5 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia